We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

216 hedge funds and large institutions have $1.35B invested in Meridian Bioscience Inc in 2022 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 67 increasing their positions, 73 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

459% more call options, than puts

Call options by funds: $5.9M | Put options by funds: $1.05M

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

50% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 22

21% more capital invested

Capital invested by funds: $1.11B → $1.35B (+$232M)

3% more funds holding

Funds holding: 210 → 216 (+6)

8% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 73

Holders
216
Holders Change
+6
Holders Change %
+2.86%
% of All Funds
3.64%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.08%
New
33
Increased
67
Reduced
73
Closed
22
Calls
$5.9M
Puts
$1.05M
Net Calls
+$4.85M
Net Calls Change
+$476K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$36.2M
2
FCM
Freshford Capital Management
New York
+$13.1M
3
Renaissance Technologies
Renaissance Technologies
New York
+$5.33M
4
N
Nuveen
North Carolina
+$4.89M
5
Neuberger Berman Group
Neuberger Berman Group
New York
+$3.79M

Top Sellers

Rank Fund Capital Flow
1
EIP
Epoch Investment Partners
New York
-$14.5M
2
RA
Royce & Associates
New York
-$9.2M
3
UBS Group
UBS Group
Switzerland
-$5.86M
4
VLKIM
Van Lanschot Kempen Investment Management
Netherlands
-$5.71M
5
BlackRock
BlackRock
New York
-$3.92M
Name Holding Trade Value Shares
Change 		Change in
Stake
FGAM
201
Financial Gravity Asset Management
Texas
$2.67K +$14.6K +540 New
S
202
SignatureFD
Georgia
$2K -$487 -18 -25%
MAM
203
Meeder Asset Management
Ohio
$2K -$297 -11 -15%
AssetMark Inc
204
AssetMark Inc
California
$2K – – –
Credit Agricole
205
Credit Agricole
France
$2K – – –
GRP
206
Global Retirement Partners
California
$2K – – –
STCOSD
207
Sageworth Trust Company of South Dakota
South Dakota
$2K +$1K +37 +116%
ZB
208
Zions Bancorporation
Utah
$1K -$352 -13 -22%
C
209
Covestor
United Kingdom
$1K -$162 -6 -19%
PA
210
Parallel Advisors
California
$1K – – –
ACM
211
AUA Capital Management
Pennsylvania
$1K +$189 +7 +30%
TCWM
212
Total Clarity Wealth Management
Illinois
$1K +$920 +34 New
PCH
213
Polar Capital Holdings
United Kingdom
$448 -$187K -6,917 -32%
Bank of Montreal
214
Bank of Montreal
Ontario, Canada
$202 -$208K -7,705 -54%
Citadel Advisors
215
Citadel Advisors
Florida
– -$1.23M -45,651 Closed
ACM
216
AlphaCrest Capital Management
New York
– -$933K -35,958 Closed
CANY
217
Caxton Associates (New York)
New York
– -$715K -27,549 Closed
NA
218
NewEdge Advisors
Louisiana
– -$643K -24,756 Closed
JAM
219
Jupiter Asset Management
United Kingdom
– -$526K -20,251 Closed
HEIP
220
Hudson Edge Investment Partners
New Jersey
– -$487K -18,762 Closed
EVM
221
Eaton Vance Management
Massachusetts
– -$482K -18,540 Closed
Wellington Management Group
222
Wellington Management Group
Massachusetts
– -$455K -17,526 Closed
EGM
223
Engineers Gate Manager
New York
– -$332K -12,774 Closed
AI
224
AdvisorShares Investments
Maryland
– -$299K -11,500 Closed
QC
225
Quadrature Capital
United Kingdom
– -$297K -11,421 Closed
6 7 8
9
10

VIVO Hedge Fund Activity: Q2 2022 in Review

216 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q2 2022, worth a combined $1.35B — up 21% from $1.11B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new VIVO positions and 22 closed out — a net gain of 11 holders — while 67 added to existing stakes and 73 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $36.2M. The largest seller was Epoch Investment Partners, cutting an estimated $14.5M.

  • 216 institutional investors held Meridian Bioscience Inc (VIVO) as of Q2 2022, up from 210 in Q1 2022.
  • Funds reported $1.35B of Meridian Bioscience Inc stock for Q2 2022, up 21% quarter-over-quarter.
  • 33 funds opened new Meridian Bioscience Inc positions in Q2 2022 and 22 closed out, a net change of +11 holders.
  • The largest Meridian Bioscience Inc buyer in Q2 2022 was Fidelity Investments, an estimated $36.2M added.
  • The largest Meridian Bioscience Inc seller in Q2 2022 was Epoch Investment Partners, an estimated $14.5M sold.

Based on aggregated 13F filings for Q2 2022.